 |
| L-R: CRM’s CEO Dr Akhmal Yusof, Health Minister Datuk Seri Dr Dzulkefly Ahmad, Director General of Health Datuk Dr Radzi Abu Hassan & PhAMA President Ms Kam Ai Teng |
PUTRAJAYA, Jan 8 (Bernama) -- Clinical Research Malaysia (CRM) and the Pharmaceutical Association of Malaysia (PhAMA) have entered a strategic partnership to propel the development of clinical research talents and skills in Malaysia. The MoU was formalized earlier today during CRM’s Clinical Research Excellence in Early Phase and People Development event in Ministry of Health office.
The MOU was signed by Dr Akhmal Yusof, Chief Executive Officer of CRM, and Ms Kam Ai Teng, President of PhAMA and was witnessed by the Minister of Health, Datuk Seri Dr Dzulkefly Ahmad. Under the MoU, PhAMA will support CRM through the provision of proteges on an annual basis for the next three years, effective this year.
The partnership will be driven through the CRM’s Centre of Excellence (CoE), which aims to enhance the nation's clinical research capabilities in building skilled study coordinators profession. This initiative will pave the way for fresh graduates to begin their career in clinical research, aligning with the Pharmaceutical Sector's Research and Development (R&D) objectives outlined in the New Industrial Master Plan (NIMP) 2030.
PARTNERSHIP TO ADVANCE NATION'S CLINICAL RESEARCH CAPABILITIES
No comments:
Post a Comment